J&J’s first psoriasis study exclusive to patients of color opens door to new marketing communicationsnews2023-10-26T18:59:48+00:00October 26th, 2023|Endpoints News|
2seventy bio stock drops 24% as competition catches up with BMS-partnered multiple myeloma drugnews2023-10-26T18:50:50+00:00October 26th, 2023|Endpoints News|
Novartis sues Takeda over trade secrets allegedly taken by former employeenews2023-10-26T18:44:21+00:00October 26th, 2023|Endpoints News|
Pendulum, a probiotics startup, delayed launch of a supplement marketed with GLP-1 namenews2023-10-26T17:27:55+00:00October 26th, 2023|Endpoints News|
WuXi TIDES boosts oligo, peptide offerings due to a rise in demand, with new builds ongoingnews2023-10-26T16:00:09+00:00October 26th, 2023|Endpoints News|
European Commission outlines how countries can share drugs to mitigate shortagesnews2023-10-26T15:51:42+00:00October 26th, 2023|Endpoints News|
Merck’s Keytruda sales eclipse $18B on the year, while numbers for Lagevrio surprisenews2023-10-26T15:36:44+00:00October 26th, 2023|Endpoints News|
Bristol Myers pushes back ‘peak’ for new product sales, citing challenging uptake for Sotyktu, Camzyosnews2023-10-26T15:27:56+00:00October 26th, 2023|Endpoints News|
A KRAS biotech from Bert Vogelstein and Catalio targets $153Mnews2023-10-26T15:17:27+00:00October 26th, 2023|Endpoints News|
EuroAPI CEO steps down; Samsung Biologics looks to Europe; Merck recalls pneumococcal vaccinesnews2023-10-26T14:32:25+00:00October 26th, 2023|Endpoints News|
